| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |